Introduction
The BiDAS-2007 [1] (Bioassay Data Analysis Software 2007) computer code was developed in 2007 by KAERI (Korea Atomic Energy Research Institute) for the purpose of estimating the radionuclide intakes and doses of a radiation worker. The BiDAS-2007 computer code enables the user to estimate the intakes of radionuclides on the basis of the bioassay measurements and the internal dosimetric parameters [2] such as the intake type (acute, chronic), the intake pathway (inhalation, ingestion), the absorption type (Type F, M, S), and the particle size(AMAD; activity median aerodynamic diameter).
However there is no function concerned with the injection of radionuclides in BiDAS-2007. In addition there is a serious problem for the evaluation logic of the Automatic mode for a chronic intake. Besides these problems, some trivial matters have been found.
To solve these problems of BiDAS-2007, the BiDAS-2009 computer code has been developed in this study. This paper describes not only the improved evaluation logic of the Automatic mode for a chronic intake but also the new and useful functions of the BiDAS-2009 computer code.
Methods and Results

Chronic Automatic Evaluation Mode of BiDAS-2009
The Automatic mode is based on the reconstruction of the intake on a basis of a multi-points approximation of observed trends of measurements. In other words, the intake of a radionuclide is automatically evaluated for several measurement data sets in the Automatic mode. When the chronic intakes are evaluated from two sets of bioassay measurement data that the time after an intake is different, an evaluation for the second bioassay data is depended on the result of an evaluation for the first bioassay data.
The chronic Automatic mode of BiDAS-2007 performs only two evaluation logic like as the IMIE computer code [3] . If the second bioassay measurement value is higher than the expected chronic intake retention at the second bioassay time on the basis of the chronic daily intake rate evaluated by the first bioassay measurement data, another chronic daily intake rate is evaluated after the first bioassay measurement time. Otherwise, the chronic intake rate is re-evaluated considering the two sets of bioassay measurement data, and the duration of a chronic intake is up to the second bioassay measurement time.
However if the second bioassay measurement value is not higher than the expected chronic intake retention evaluated by the first bioassay measurement data, the evaluation logic has to be divided into the four conditions as follows.
1) The 2 nd bioassay data is included in the expected chronic intake retention according to the daily intake rate evaluated by the 1 st bioassay data 2) The 2 nd bioassay data is between the expected chronic intake retention according to the daily intake rate by the 1 st bioassay data and the expected retention without any more chronic intake after the chronic intake up to the 1 st bioassay measurement time 3) The 2 nd bioassay data is included in the expected retention without any more chronic intake after the chronic intake up to the 1 st bioassay measurement time In the case of the 1 st condition, the chronic intake rate is re-evaluated considering the two sets of bioassay measurement data and the duration of chronic intake is up to the second bioassay measurement time in the same way like BiDAS-2007. In the case of the 2 nd condition, another new chronic daily intake rate is evaluated by the 2 nd bioassay data. In the case of the 3 rd condition, the 2 nd bioassay data is regarded as the retention after the chronic intake up to the 1 st bioassay measurement time and is not considered in the evaluation of chronic intake.
In a case that the thyroid bioassay data of 131 I are the same as Table 1 which is the 3 rd condition mentioned above, the chronic intake of Table 1 . In contrast, Figure 2 shows the result by the chronic Automatic mode of BiDAS-2009, 2 nd bioassay data was regarded as the retention after the 1 st chronic intake, on the basis of 
Addition of an Injection in the Intake Pathway
The function of injection has been added to the intake pathway in the BiDAS-2009. The intake retention rates of the whole-body, thyroid, urine or feces excretion rates and the dose coefficients due to the injection of a radionuclide are expected to adopt and able to be used for the evaluation of injected intakes in the BiDAS-2009. The intake retention rates of the whole-body, thyroid and urine or feces excretion rates after an injection of radionuclides have been calculated by using the Mathcad software program. The dose coefficients in the IDEA System [4] computer code have been used as the dose coefficients for injection of radionuclides in the BiDAS-2009
Upgrade of Reference Mode and other function
The Reference mode of the BiDAS-2009 shows a half life and the committed effective dose coefficient depended on a radionuclide and several dosimetric parameters such as the intake pathway, AMAD (activity median aerodynamic diameter, and absorption type (Type F, M, S) or f 1 value as well as the intake retention fraction or excretion rate after injected intakes. Figure 3 shows the upgraded Reference mode of the BiDAS-2009. 
Conclusions
The BiDAS-2009 computer code has been developed and upgraded from the BiDAS-2007 computer code developed in 2007 by KAERI for the purpose of estimating the radionuclide intakes and doses of a radiation worker. The features of the BiDAS-2009 are the new evaluation logic for the chronic Automatic mode, the injection function of an intake pathway, the upgraded Reference mode, and the User's Guide in the Help mode. In conclusion, the BiDAS-2009 is more useful and user-friendly as well as more reliable to estimate the radionuclide intakes and doses of a radiation worker than the BIDAS-2007.
